Clinical Trial Update: Immunity and Safety of Covid-19 Synthetic Minigene Vaccine [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the immunogenicity and safety of a Covid-19 synthetic minigene vaccine from Shenzhen Geno-Immune Medical Institute. Current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection

Drugs mentioned

• Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Pathogen Infection Covid-19 Infection | Phase 1, Phase 2 | Status: UNKNOWN